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Critical Roles for Transcription Factor GATA-3
in Thymocyte Development
chains, or deficiency of various components of the pTCR
signaling complex results in arrest in development at
the DN3 stage (Cheng et al., 1997; Clements et al., 1998;
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Children’s Hospital van Oers et al., 1996; Wolfer et al., 2002; Zhang et al.,
1999). In contrast, cells that successfully pass the Boston, Massachusetts 02115
2 Harvard Medical School selection checkpoint activate multiple signaling cas-
cades that in turn trigger rapid proliferation, rescue fromBoston, Massachusetts 02115
3 Center for Prevention of Cardiovascular Disease apoptosis, and differentiation into the DN4 (CD44
CD25) stage.Harvard School of Public Health
4 Division of Immunology and Infectious Diseases After passing through an intermediate single-positive
(ISP) stage (CD8med CD5low TCRlow), -selected thymo-Harvard School of Public Health
Boston, Massachusetts 02115 cytes differentiate into CD4 CD8 (double-positive or
DP) thymocytes. DP thymocytes then must survive posi-5 Division of Rheumatology, Immunology and Allergy
Brigham and Women’s Hospital tive and negative selection, the second critical check-
point (reviewed in Sprent and Kishimoto, 2002; Starr etBoston, Massachusetts 02115
al., 2003). Only a small fraction of DP thymocytes sur-
vive, differentiating into cells singly positive for CD4 or
CD8 (SP CD4 or SP CD8) that are then exported to theSummary
periphery. Successful generation of mature CD4 T cells
requires commitment to the CD4 lineage; postcommit-The transcription factor GATA-3 is expressed at every
stage of thymic development, but its role in thymocyte ment events then ensure survival in the periphery. The
process by which CD4/CD8 lineage commitment occursdifferentiation is unknown. The fact that RAG chimeric
animals lacking GATA-3 cannot generate early thymo- has been heavily investigated, and conflicting lines of
evidence support stochastic, instructive, and corecep-cytes from common lymphoid progenitors has thus
far precluded investigation of the function of GATA-3 tor reversal models (reviewed in Germain, 2002; Singer,
2002). Some signaling molecules, such as lck and Erk,in the thymus. To address this, we generated mice
deficient in GATA-3 at early and late stages of thymic may act as a lineage switch, based on experiments
showing that high kinase activity can drive the genera-differentiation. Our studies revealed that GATA-3 is
involved in  selection and is indispensable for single- tion of CD4 T cells even in animals expressing an MHC
class I-restricted transgenic TCR, while low kinase activ-positive CD4 thymocyte development. Thus, our data
demonstrate that the coordinated and regulated ex- ity promotes the development of CD8 MHC class II-
restricted cells (Hernandez-Hoyos et al., 2000; Legnamepression of GATA-3 at each stage of thymic develop-
ment is critical for the generation of mature T cells. et al., 2000; Sharp and Hedrick, 1999). The transcription
factors downstream of these signals that control the
generation and maintenance of the CD4 lineage are cur-Introduction
rently unknown.
GATA-3 is a zinc finger transcription factor that isLymphoid progenitors committed to the T lineage must
differentiate in the thymus prior to becoming fully func- essential for the differentiation of common lymphoid
progenitors into early DN thymocytes (Ting et al., 1996).tional peripheral / T cells. Maturation of / T cells
in the thymus ensures that only thymocytes bearing a GATA-3 is expressed throughout thymic development
(Hendriks et al., 1999) but its role in DN, DP, and SPfunctional TCR will be selected at critical developmental
checkpoints and escape apoptotic death. The first criti- thymocyte differentiation is unknown. In vitro studies
cal checkpoint occurs in very early CD4 CD8 double- implicate GATA-3 in the control of transcription of multi-
negative (DN) thymocytes, which are further subdivided ple TCR chains (Henderson et al., 1994; Ho et al., 1991;
into four stages (DN1–4) based on their surface expres- Joulin et al., 1991) as well as the CD8molecule (Landry
sion of CD44 and CD25. At the DN3 stage (CD44 et al., 1993), suggesting that GATA-3 might be essential
CD25), those cells that have productively rearranged for thymic development. To test this hypothesis, we
a T cell receptor  (TCR) gene assemble the pre-T cell generated mice conditionally deficient in GATA-3 at the
receptor (pTCR), in which TCR is paired with the pre-T DN and DP stages, and uncovered novel roles for
cell receptor  (pT) chain. The formation of a functional GATA-3 in thymic differentiation. Specifically, we dem-
pTCR is required for DN3 cell survival, a process also onstrate here that GATA-3 is crucial for thymocytes to
termed  selection (reviewed in Borowski et al., 2002; pass through  selection and that, without GATA-3, thy-
Michie and Zuniga-Pflucker, 2002). Failure of  selection mocytes committed to the CD4 lineage either cannot
caused by lack of rearrangement, lack of pT or TCR be generated or fail to survive. The coordinated and
continued expression of GATA-3 is thus clearly required
at multiple stages of thymocyte differentiation.*Correspondence: iho@hsph.harvard.edu
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Figure 1. Conditional Deletion of Murine GATA-3 in Thymocytes
(A) Schematic of native murine GATA-3 locus, targeting construct, floxed locus after homologous recombination, and locus after Cre-mediated
excision. The locations of probe used in (B), transcriptional start site (*), loxP sites, restriction enzyme sites (Cl, ClaI; B, BamHI; RI, EcoRI;
RV, EcoRV; H3, HindIII), and primers used for PCR analyses (1–6) are shown. The black boxes stand for exons. PGK denotes a PGK promoter,
HSV-tk the HSV thymidine kinase gene, and neo the neomycin resistance gene.
(B) Genomic Southern blot (upper panel) detecting a smaller 10 kb wild-type ClaI-EcoRV fragment and a larger 13 kb flox fragment using the
probe indicated in (A) and genomic PCR (lower panel) showing a larger 494 bp wild-type and smaller 334 bp flox product are shown. Results
using DNA from wild-type (WW), heterozygous flox (WF), and homozygous flox (FF) animals are shown.
(C) Level of GATA-3 protein in thymocytes from WW, WF, and FF mice seen by Western blot analysis with the expected size of GATA-3
indicated by the arrow. The band between 37 and 50 kilodaltons seen in the WW lane is not reproducible.
(D) Western blot analysis of GATA-3, indicated by the arrow, using whole-cell thymocyte lysates from mice of the indicated genotypes is
depicted (upper panel). The CD4/CD8 ratio and total thymocyte number in millions of cells in these mice is indicated below. Equal loading
was confirmed by stripping and reprobing the membrane with antibody to actin (lower panel).
(E) PCR showing the relative proportion of flox allele (flox) and deleted (del) alleles in genomic DNA prepared from whole thymus of the
indicated genotypes (upper panel). A similar analysis using genomic DNA from sorted thymocyte populations is also shown (lower panel).
DN3, DP, and SP CD4 (SP4) thymocytes were obtained from FF/lck-cre animals and compared with whole thymus (th) from FF and FF/lck-
cre animals. In both panels, the first lane (m) had molecular weight markers, and the lane marked with  had no input DNA.
Results contain the zinc finger domains, was replaced with a
cassette containing exons 4, 5, and 6, flanked by loxP
sites, creating a “floxed” allele. A PGK promoter and theGeneration of Mice Conditionally
Deficient in GATA-3 sequence encoding enhanced green fluorescent protein
(EGFP) were engineered such that deletion of the cas-To study the role of GATA-3 in the development and
function of T cells, we generated mice conditionally defi- sette containing exons 4, 5, and 6 would place the PGK
promoter immediately upstream of EGFP, with the inten-cient in GATA-3 using the Cre-lox system (Sauer, 1998).
The targeting construct is shown in Figure 1A. Using tion that the cells would thus be marked after Cre-medi-
ated excision. Germline transmission from two chimericstandard homologous recombination techniques, the
region of murine GATA-3 encoding exons 4 and 5, which animals was confirmed by Southern blotting and PCR
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Figure 2. Abnormal Thymocyte Development of FF/lck-cre Mice
(A) Number of total thymocytes from WW (n  18), FF (n  10), and FF lck-cre (n  27) with each circle representing an individual mouse.
The average number is indicated by the horizontal line.
(B) Number of total thymocytes and of DN, DP, SP CD4, and SP CD8 subsets from the first six litters of wild-type (WW, WW/lck-cre),
homozygous flox (FF), and knockout (FF/lck-cre) mice. Error bars denote standard deviation.
(C) Representative FACS analysis of thymocytes from WW, WW/lck-cre, FF, and FF/lck-cre mice stained with antibodies against CD4 and
CD8. The total thymocyte numbers of these mice were 1.66  108, 2.02  108, 1.50  108, and 6.2  106, respectively. The percentages of
DN, DP, SP CD4, and SP CD8 cells are indicated.
(D) Representative FACS analysis of DN thymocytes from WW, WW/lck-cre, FF, and FF/lck-cre mice, gating on cells negative for CD4 and
CD8, then stained with antibodies against CD44 and CD25. The percentages of DN1 (CD44 CD25), DN2 (CD44 CD25), DN3 (CD44
CD25), and DN4 (CD44 CD25) subsets are indicated.
(Figure 1B), and all results presented here were ob- These FF mice were then crossed to mice carrying
a transgene for Cre, either driven by the proximal lckserved in both lines. Animals bearing one floxed allele
(WF) were intercrossed to generate homozygous flox promoter (lck-cre) or by the CD4 promoter (CD4-cre) to
delete the GATA-3 gene at the DN3 or DN4/DP stages,(FF) animals, which had near normal amounts of thymic
GATA-3 protein (Figure 1C) and normal numbers of thy- respectively (Lee et al., 2001; Wolfer et al., 2002). The
construct design was intended to distinguish deletedmocytes and thymic subsets (Figure 2 and data not
shown); therefore, we considered FF mice to be essen- from nondeleted cells by GFP expression; indeed, GFP
expression was detected when ES cells bearing onetially equivalent to wild-type mice. Because a PGK pro-
moter was inserted upstream of the engineered region floxed allele were transfected with Cre plasmid (data not
shown). However, in thymus, lymph node, and spleen ofencoding exons 4–6 in the recombination cassette, it
was possible that a zinc finger only truncated protein FF mice crossed with Cre transgenic mice, less than
1% of the cells, if any, expressed GFP, which likelycould be generated in the FF animals; however, no
shorter transcript or protein was detected by Northern or results from weak activity of the PGK promoter in these
tissues compared to embryonic tissues. Western analy-Western analysis (data not shown). In addition, Western
blotting did not reveal any truncated protein that could sis confirmed that both sets of knockout mice have
reduced amounts of GATA-3 protein (Figure 1D), thoughencode exons 2 and 3 in any of the knockout animals
(data not shown). the degree of GATA-3 deficiency in FF/lck-cre mice was
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highly variable. As discussed later, the severity of the We then investigated the mechanism of the DN3 ar-
phenotype observed varied with the level of remaining rest. DN3 cells typically manifest a characteristic change
GATA-3 protein. In FF/lck-cre animals that had a severe in cell size as they undergo  selection. The smaller,
phenotype and in all FF/CD4-cre animals examined, less mature cells, termed E cells, have not yet fully re-
PCR analysis of genomic DNA from whole thymus con- arranged TCR, whereas the larger L cells have com-
firmed near complete deletion of the GATA-3 gene (Fig- pleted VDJ recombination, begin to assemble the pTCR,
ure 1E, upper panel). Whole thymus would include DN1 and go on to differentiate into DN4 and later DP cells
and DN2 cells that had not yet expressed lck-cre and (Hoffman et al., 1996). We thus examined the percentage
DN cells that had not yet expressed CD4-cre; thus, the of L cells as a surrogate marker of whether events down-
trace amount of remaining floxed allele and GATA-3 stream of pTCR assembly had occurred. On average,
protein is consistent with the proportion of nondeleted 14%–30% of DN3 cells in wild-type or FF animals were
cells expected. These PCR findings correlated well with larger by analysis of forward scatter. In contrast, FF/
Southern blotting analysis (data not shown). In addition, lck-cre DN3 cells had less than half as many L cells,
PCR analysis of DNA from sorted thymocyte subsets in ranging from 2%–10%. A representative experiment is
severely affected FF/lck-cre mice confirmed that dele- shown in Figure 3A. Thus, FF/lck-cre DN3 thymocytes
tion was practically complete in DN3, DN4, and DP failed to undergo the changes in cell size that precede
stages (Figure 1E, lower panel). SP CD4 cells in contrast their differentiation into DN4 cells, presumably due to
had a mixture of deleted and nondeleted DNA (Figure insufficient signals via the pTCR.
1E, lower panel). In addition to changes in cell size, thymocytes under-
going proper  selection should be rescued from apo-
Mice Lacking GATA-3 in the DN Stage Have ptosis. We therefore examined the degree of apoptosis
Abnormal Thymic Development in FF/lck-cre mice by Annexin V staining. FF/lck-cre ani-
FF animals carrying the lck-cre transgene (FF/lck-cre mals had increased levels of Annexin V staining in most
mice) were normal in appearance and size, and showed thymic subsets, 2- to 8-fold higher than WW or FF lit-
no gross abnormalities. Among the first 124 animals termates, except in the total DN population (Table 1).
born from WF animals crossed with WF/lck-cre animals, We also examined the percent of Annexin V-stained
only 6.5% were FF/lck-cre, versus 12.5% as expected, cells within the DN1–4 populations and found that DN4
suggesting that there might have been misexpression cells in FF/lck-cre mice had more apoptosis than DN4
of Cre in a nonspecific manner during embryonic devel- cells in control animals (Figure 3B). In contrast, DN3 cells
opment, causing embryonic lethality. Mice were ana- from FF and FF/lck-cre mice had equivalent amounts
lyzed between 4–6 weeks of age, and the number of of apoptosis (Figure 3B). Thus, those DN3 cells that
total thymocytes is shown in Figure 2A. The average successfully developed into DN4 cells in the absence of
total thymocyte number was 9.5, 12.2, and 2.9  107 in GATA-3 were more prone to apoptosis at the DN4 stage.
wild-type mice, FF mice, and FF/lck-cre mice, respec-
tively. In most experiments, FF/lck-cre mice had approx- FF/lck-cre DN3 Cells Are Deficient
imately a 10-fold reduction in the number of / TCR in T Cell Receptor  Protein
thymocytes compared to littermate controls. There was
On the basis of our findings that FF/lck-cre DN3 thymo-
considerable variability in the phenotype with a few mice
cytes failed to develop into L cells and that there was
having normal thymus size (Figure 2A), likely due to
increased apoptosis in all stages following DN3, we sus-incomplete excision of the GATA-3 gene by lck-driven
pected that pTCR signaling was deficient in these ani-Cre. Indeed, Western blotting confirmed that those ani-
mals. As stated in the Introduction, GATA-3 is knownmals with near normal thymocyte number (70–200 mil-
to bind the TCR enhancer, and TCR is required tolion total) in general had a substantial amount of GATA-3
form the pTCR. We found that FF/lck-cre DN3 thymo-protein remaining while those with small thymus size
cytes had lower amounts of intracellular TCR protein(less than 20 million total) had much less (Figure 1D).
by FACS staining (Figure 3C). In addition, only aboutFACS analysis of the first six litters of mice after staining
40% of FF/lck-cre DN4 cells, in comparison to 85%–90%for CD4 and CD8 showed that the absolute number of
of wild-type DN4 cells, contain a detectable amount ofDN cells was preserved but that the DP and SP CD4 cell
intracellular TCR protein (Figure 3C). Thus, not onlynumbers and percentages were markedly decreased
were there few DN4 cells, but half of those that matured(Figures 2B and 2C). The total SP CD8 cell number was
did so in the absence of pTCR expression. We showedalso decreased, though in some cases the percentage
that these TCR-negative DN4 cells were not contami-was higher than in wild-type mice (Figure 2C). Overall,
nants by confirming that these cells were CD2 positiveabout two-thirds of FF/lck-cre mice had less than 20
(data not shown). One possible explanation for thesemillion thymocytes, of which approximately 30%–60%
findings is that those DN4 cells with adequate intracellu-were DN cells and 20%–60% were DP cells, suggesting
lar TCR protein could have failed to delete GATA-3.a partial developmental arrest from the DN to the DP
However, PCR analysis confirmed that the majority ofstage. To further characterize the defect, thymocytes
DN4 and DP cells in these animals had indeed deletedwere stained with antibodies against CD4, CD8, CD44,
the GATA-3 gene (Figure 1E, lower panel).and CD25 to separate the DN1–4 stages. This revealed
DN3 cells in Notch-1 conditionally deficient animalsa relative accumulation of cells in the CD44 CD25
also have reduced intracellular TCR protein, and DN4DN3 stage with a deficiency of CD44 CD25 DN4 cells
cells in these animals can mature in the absence of(Figure 2D). Thus, FF/lck-cre mice had markedly de-
pTCR; these mice have been shown to have a defectcreased numbers of mature / T cells due to partial
arrest at the DN3 to DN4 transition. in TCR gene rearrangement (Wolfer et al., 2002). We
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Figure 3. FF/lck-cre DN3 Thymocytes Have Deficient  Selection and Have Low Intracellular TCR Levels
(A) The percentage of L cells within the DN3 population by FACS analysis, gating on CD4 CD8 CD44 CD25 thymocytes, then analyzing
forward scatter of thymocytes from mice of the indicated genotypes is shown.
(B) Thymocytes negative for CD4, CD8, and CD44 were divided into DN3 and DN4 populations by CD25 staining, and the percentage of cells
positive for Annexin V staining was measured by FACS analysis.
(C) DN3 and DN4 thymocytes of indicated genotypes were permeabilized, stained with antibody against TCR (bold histogram) or isotype
control antibody (light histogram), and analyzed by FACS. The percentage of intracellular TCR-positive cells is indicated.
(D) Genomic DNA from DN3 thymocytes of FF or FF/lck-cre mice was purified and subjected to PCR amplication using primers derived from
V5.1, V8.2, and D-J regions of TCR. The presence or absence of lck-cre transgene is noted by  and  symbols. The PCR products were
then analyzed by Southern blotting using the D-J unrearranged PCR product as probe (upper panels). Reprobing membranes with probe to
Thy-1 confirmed equal loading (lower panels).
(E) Real-time PCR analysis showing levels of TCR transcript relative to -actin control detected in cDNA prepared from FF or FF/lck-cre
DN3 and DN4 thymocytes. Results using cDNA prepared from B cells (B) served as a negative control. All reactions were run in triplicate,
and error bars denote the standard deviation.
therefore examined TCR rearrangement in our animals (Figure 3D). This observation is in agreement with our
finding that the TCR repertoire in mature SP cells fromby purifying DN3 thymocyte genomic DNA, amplifying
across V-J and D-J segments, and detecting the various these animals was normal (data not shown). Given that
rearrangement was normal, we also examined transcrip-sized products by Southern blotting, but were unable
to detect any deficiency in TCR gene rearrangement tion. Real-time PCR analysis of RNA from purified DN3
Immunity
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TCR expression and signaling were restored, the partialTable 1. Fold Change in Percentage of Annexin V-Positive Cells
Comparing Control Thymocytes to FF/lck-cre Thymocytes DN3 arrest seen in FF/lck-cre mice was not corrected
by provision of a functional TCR. These observationsDN DP SP4 SP8 All Subsets
argue that, in addition to regulating TCR protein levels,
Experiment 1 1.7 8.7 2.5 3.5 7.4 GATA-3 also may play a critical role in events down-
Experiment 2 1.5 5.7 6.5 5.6 3.4
stream of the pTCR that are required for the progressionExperiment 3 1.2 3.0 2.4 6.3 3.3
from the DN3 to the DN4 stage.
Thymocytes from control and FF/lck-cre littermates were stained
with antibodies to CD4 and CD8, and then stained with Annexin V
reagent. The percentage of Annexin V-positive cells was measured
Deletion of GATA-3 after  Selection Resultsby FACS analysis in total thymocytes and in each thymocyte subset,
in a Profound Deficiency of SP CD4 Cellsand then expressed as fold change compared to control animals.
The control animal was a WW animal in Experiment 2 and a FF FF/lck-cre mice have a reduced CD4/CD8 ratio in the
animal in Experiments 1 and 3. thymus, suggesting that GATA-3 may affect the CD4/
CD8 lineage determination (Figures 2B and 2C). This
was especially striking in the mice with small thymus
size, with an average CD4/CD8 ratio of 1.33 in mice withand DN4 thymocytes surprisingly showed that the
less than 20 million total thymocytes compared to aamount of TCR message was also normal (Figure 3E).
normal ratio of 3 or 4. As discussed above, there wasIt is possible, therefore, that GATA-3 controls the ex-
clearly incomplete excision of the GATA-3 gene in indi-pression of TCR in DN3 cells by an as yet uncharacter-
vidual FF/lck-cre mice; Figure 1D shows that those FF/ized posttranscriptional mechanism.
lck-cre mice with a more striking reversal in CD4 to
CD8 ratio had much less GATA-3 protein remaining thanTCR Transgene Expression Failed to Rescue
those with a normal ratio. These data implied that GATA-3the DN3 Arrest in FF/lck-cre Mice
is necessary to generate or maintain SP CD4 cells andOur findings suggested that the thymus in FF/lck-cre
that the amount of GATA-3 protein determines the SPmice was small due to partial DN3 arrest, which in turn
CD4 cell number. To confirm this observation and towas caused by deficient TCR protein and insufficient
eliminate the confounding effect of the DN3 arrest seenpTCR signaling. If deficient pTCR expression were the
in FF/lck-cre mice, we examined thymocyte develop-only cause of the DN3 arrest, and if DN3 arrest were the
ment in FF mice crossed with CD4-cre transgenic ani-only barrier to the generation of DP cells, the provision
mals (FF/CD4-cre).of a functional, rearranged TCR transgene would be
Because CD4-cre mediated excision occurs after expected to overcome the DN3 arrest and potentially
selection (Lee et al., 2001; Wolfer et al., 2002), FF/CD4-restore thymocyte numbers. To test this hypothesis, FF/
cre animals should not suffer from DN3 arrest and thuslck-cre mice were crossed to DO11.10 (DO11) TCR
should have normal numbers of thymocytes. Indeed,transgenic animals. The DO11 transgene encodes an
total thymocyte number was preserved in these animals/ TCR that is fully rearranged, MHC class II restricted,
(Figure 5A); however, the percentage of SP CD4 thymo-and specific for ovalbumin peptide (Murphy et al., 1990).
cytes was dramatically reduced from 10%–15% in con-Approximately 30%–60% of FF/lck-cre/DO11 DN3 (CD4
trol animals to 3% or less in FF/CD4-cre animals (FigureCD8 CD44 CD25) cells were positive for the DO11
5B). This was also reflected in the absolute numbers,transgene, confirming appropriate expression (Figure
where SP CD4 cell number was at least one log lower,4A). In Figure 4B we show that FF/lck-cre/DO11 DN3
while the number of SP CD8 cells was normal and notcells expressed the DO11 transgene at high levels; FF/
increased above control (Figure 5A). The CD4 promoterDO11 DN3 cells were mostly DO11 negative. In addition,
used to drive the cre transgene does not contain theas shown in Figure 4A, the percentage of DO11 L cells
intronic silencer (Sawada et al., 1994) and is thereforewas increased to 21%, as compared to 12% of DO11
active in both SP CD4 and SP CD8 populations. Indeed,population, indicating that at least some TCR signals in
nearly 100% of DP and SP CD8 cells of FF/CD4-cre miceDN3 cells were restored by the DO11 transgene. How-
have undergone Cre-mediated deletion (Figure 5C). Theever, the thymus of FF/lck-cre/DO11 animals remained
preservation of SP CD8 cell number argued against asmall, with preservation of total DN cell number and
general defect in positive selection. Indeed, CD4highmore than 10-fold reduction in DP and SP CD4 number
CD8med cells gated as shown in Figure 5B were mostly(Figure 4C). The SP CD8 number was also decreased
CD69high in both FF and FF/CD4-cre animals, confirmingthough less dramatically. Subset analysis of total thymo-
that positive selection was occurring (Figure 5D). Fur-cytes (data not shown) or gating only on DO11 cells
thermore, SP CD8 thymocytes in FF/CD4-cre mice were(Figure 4D) revealed persistent abnormalities. Thus,
mature with high levels of CD5 and had high levels ofDO11 FF/lck-cre cells were partially deficient in the
surface TCR, though slightly lower than wild-type lev-generation of DP cells, similar to nontransgenic knock-
els (Figure 5D). Thus, the reversal in CD4 to CD8 ratioout cells.
was even more striking in the FF/CD4-cre mice than inIn wild-type DO11 mice, DO11 DN3 cells rapidly pro-
FF/lck-cre mice, supporting a dose dependence of CD4gressed to the DN4 stage, and approximately 70%–80%
number on the amount of GATA-3 protein. These obser-of the CD4 CD8 CD44 (DN3 and DN4) population
vations indicate that, once thymocytes reach the DPwas CD25 DN4 cells (Figure 4E). In contrast, DO11
stage, GATA-3 is essential for further development ofknockout cells accumulated at the DN3 (CD25) stage,
SP CD4 cells but dispensable for the maturation of SPdemonstrating persistence of the DN3 arrest even in the
presence of a functional TCR (Figure 4E). Thus, while CD8 cells.
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Figure 4. Analysis of Thymocytes from FF/lck-cre DO11 Mice
(A) DN3 thymocytes from FF/lck-cre/DO11 mice were gated as in Figure 3A and analyzed for staining for DO11 transgene as shown in the
left panel, with the percentages of DO11 and DO11 DN3 cells as indicated. Analysis of these cells by forward scatter and the percentage
of L cells in each population are shown in the right two panels.
(B) DN3 cells from FF DO11 (light histogram) and FF/lck-cre/DO11 mice (bold histogram) were analyzed by gating on CD4 CD8 CD44
CD25 cells, and the level of DO11 transgene expression was compared.
(C) Total thymocyte number and numbers of DN, DP, SP CD4, and SP CD8 subsets from control DO11 transgene-positive and FF/lck-cre
DO11 transgene-positive (FF/lck-cre DO11) mice. Control DO11 mice were one each of WW, WF, and FF genotypes. Standard errors are
indicated by error bars.
(D) FACS analysis showing CD4 and CD8 staining of thymocytes gating on DO11 transgene-positive cells from mice of the indicated genotypes.
The percentages in each quadrant are shown.
(E) DN thymocytes that were CD4 CD8 CD44 and DO11 transgene positive were gated as indicated in the left panel. The percentage of
cells that were CD25 (DN3) and CD25 (DN4) within this population in control DO11 and FF/lck-cre DO11 mice are shown.
GATA-3-Deficient Mice Have a Postcommitment proteins in thymocytes left unstimulated, stimulated with
antibodies to CD3 alone, or stimulated with CD3 andDefect in CD4 Thymocyte Generation
Having found that mice lacking GATA-3 after  selection CD4 combined resulted in an increase in tyrosine-phos-
phorylated ZAP70 and lck in response to stimulation.were highly deficient in CD4 cells, we questioned whether
GATA-3 is necessary for commitment to the CD4 lineage However, no consistent differences in the amount of
phosphorylated lck in WW, FF, or FF/CD4-cre animalsor alternatively for CD4 survival or maintenance. As dis-
cussed in the Introduction, strength of TCR signaling, were seen (Figure 6A). In specific immunoprecipitation
assays for lck, the amount of activated lck in FF andin particular the levels of phospho-lck and phospho-
Erk, has also been shown to affect the CD4/CD8 lineage FF/CD4-cre thymocytes appeared equivalent when
compared to loading controls (two representative exper-decision. Western blotting for tyrosine-phosphorylated
Immunity
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Figure 5. FF/CD4-cre Mice Are Severely Deficient in CD4 SP Thymocytes
(A) Total number of thymocytes and absolute numbers of DN, DP, SP CD4, and SP CD8 cells from WW/CD4-cre, WF/CD4-cre, and FF/CD4-
cre mice. Error bars indicate standard deviation.
(B) FACS analysis of thymocytes from FF and FF/CD4-cre mice stained with antibodies against CD4 and CD8. The percentages of DN, DP,
SP CD4, and SP CD8 cells are indicated.
(C) PCR detecting floxed and deleted alleles in sorted thymocyte populations from FF/CD4-cre mice. DN3, DP, and SP CD8 (SP8) cells were
obtained from FF/lck-cre animals and compared with whole thymus (th) from FF and FF/lck-cre animals. The first lane (m) had molecular
weight markers and the lane marked with  had no input DNA. The locations of floxed (flox) and deleted (del) alleles are indicated by the arrows.
(D) FACS analysis of CD69 surface expression in FF/CD4-cre mice. CD4high CD8med cells were gated as shown by the box in (B), and the level
of CD69 expression in FF (light histogram) and FF/CD4-cre mice (bold histogram) is indicated by the arrows.
(E) FACS analysis of CD5 and TCR surface expression in FF/CD4-cre mice. The levels of the indicated molecules are shown after gating on
DP cells (light histogram), FF SP CD8 cells (dashed histogram), and FF/CD4-cre SP CD8 cells (heavy histogram).
iments shown in Figure 6B). We also did not detect a CD8 cells. This has been seen in mice expressing a
catalytically inactive form of lck, which develop MHCconsistent difference in the level of phosphorylated Erk,
a further downstream target of TCR signaling, in sorted class II-restricted CD8 cells (Hernandez-Hoyos et al.,
2000). Subset analysis of the FF/CD4-cre mice crossedDP thymocytes (Figure 6C). Thus, we could not ascribe
the lack of CD4 cells in FF/CD4-cre mice to weaker TCR with DO11 was performed, gating on cells expressing
DO11 transgene. Single-positive thymocytes in controlsignaling, leading to a failure of commitment to the CD4
lineage. The kinetics of signaling or the activation of DO11 animals were mostly SP CD4 cells; in contrast,
FF/CD4-cre DO11 animals had a severe lack of SP CD4other molecules not examined could possibly be af-
fected, or, alternatively, GATA-3 could be required at a cells and no enrichment of SP CD8 cells (Figure 6D). The
FF/CD4-cre DO11 SP CD8 cells that were generated,level of signaling downstream from the relatively proxi-
mal events examined. though transgene-positive, were CD5low, CD69low, and
HSAhigh, characteristic of ISP cells rather than mature SPAs a more definitive test of whether GATA-3 deter-
mines the CD4 lineage, FF/CD4-cre mice were crossed CD8 cells (data not shown). As a positive control, FF/
CD4-cre mice crossed with OT-1 mice, which carry anwith DO11 mice. If the absence of GATA-3 were suffi-
cient to drive cells into the CD8 lineage, we would expect MHC class I-restricted TCR transgene, were fully capa-
ble of generating SP CD8 cells (Figure 6E). Thus, GATA-3to see an enrichment of transgene-positive mature SP
Role of GATA-3 in Thymocyte Development
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Figure 6. FF/CD4-cre Mice Signal Normally and Have a Postcommitment Defect in CD4 T Cell Generation
(A) Whole-cell lysates from thymocytes left unstimulated (none), stimulated by crosslinking CD3 (CD3), or crosslinking CD3 and CD4 (CD3 
CD4) were subjected to Western blotting analysis using anti-phosphotyrosine antibody. The areas representing phospho-ZAP70 and phospho-
lck are indicated by arrows. Thymocytes from WW, FF, and FF/CD4-cre mice (KO) were analyzed.
(B) Western blotting of lck immunoprecipitates with anti-phospho-Src antibody from two experiments is shown with lck loading controls
below. Thymocytes from FF or FF/CD4-cre mice (KO) were left unstimulated or stimulated by crosslinking CD3 and CD4. The arrow indicates
the expected position of lck, and the band below the arrow represents heavy chain of immunoglobulin.
(C) The level of phospho-Erk by direct Western blotting of stimulated sorted DP thymocyte lysate from mice of the indicated genotypes is shown.
(D) FACS analysis of thymocytes stained with antibodies against CD4 and CD8 from FF DO11 mice and FF/CD4-cre DO11 mice, gating on
transgene-positive cells. Percentages of DO11 DN, DP, SP CD4, and SP CD8 cells are indicated.
(E) FACS analysis as in (D) using thymocytes from FF OT-1 and FF/CD4-cre OT-1 mice.
deficiency did not result in an inability to generate SP block at the DN3 stage or at the DP stage could have
CD8 cells in the appropriate context. Taken together, been expected if GATA-3 were critical to the function
our data demonstrate that GATA-3 deficiency results in a of these enhancers. Our analysis of mice conditionally
severe postcommitment defect in CD4 T cell generation deficient in GATA-3 at the DN3 stage revealed instead
and/or survival. a partial DN3 arrest and reduced numbers of DN4 and
DP cells. Given that GATA-3 is thought to regulate multi-
ple TCR genes, this result could easily have been ex-Discussion
plained by deficient expression of pTCR components.
That TCR transcription appeared normal and that ma-The precise function of GATA-3 in DN thymocytes has
ture SP CD8 cells in FF/CD4-cre mice expressed a nearyet to be studied. Prior to these experiments, a role
normal level of functional / TCR with a diverse reper-for GATA-3 in thymocyte development was predicted
toire (Figure 5E and data not shown) calls into questionbased on the presence of GATA-3 binding sites in the
TCR, TCR, and TCR enhancers. Indeed, a profound the importance of GATA-3 for transcriptional regulation
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of TCR genes in vivo. Our findings argue that GATA-3 restricted AND TCR transgenic mice, T cells were di-
verted into the CD8 lineage, similar to mice expressingdeficiency may lead to low levels of TCR in DN3 cells
because of defects in translational efficiency or post- inactive forms of lck or Erk. Thus, the HD gene product,
as yet unknown, is necessary for commitment to thetranslational processing, which have not been pre-
viously described. CD4 lineage (Keefe et al., 1999). CD83, on the other
hand, is expressed on thymic epithelium and interactsNot only did we find that the low levels of TCR protein
in GATA-3-deficient DN3 cells occurred in the face of with an ill-defined ligand, CD83L, on thymocytes. Mice
deficient in CD83 lack CD4 T cells, but in contrast tonormal transcription, a surprising result, but our TCR
transgenic experiments further demonstrate that TCR- HD mice, fail to develop either mature CD4 or CD8 cells
when crossed to the AND TCR transgenic (Fujimoto etsufficient thymocytes deficient in GATA-3 were still sig-
nificantly arrested. Thus, we propose that GATA-3, inde- al., 2002). GATA-3-deficient TCR transgenic mice more
closely resembled CD83-deficient animals in our experi-pendent of its role in regulating the expression of pTCR
components, may be required for optimal pTCR signal- ments, suggesting that GATA-3 is necessary for post-
commitment CD4 generation or survival, rather than foring and function. One key function of the pTCR is to
rescue DN3 thymocytes from death by apoptosis (re- commitment to the CD4 lineage. That we did not see
alterations in lck or Erk signaling further is consistentviewed in Marsden and Strasser, 2003; Michie and Zun-
iga-Pflucker, 2002), and indeed we found that GATA- with our conclusion that lineage commitment is intact.
Whether GATA-3 and CD83L directly regulate each other3-deficient DN4 cells were more apoptotic (Table 1).
Alternatively, it is also possible that GATA-3 may be or whether signals from both pathways converge to gen-
erate SP CD4 thymocytes is unclear.required for promotion of DN3 differentiation through
pathways separate from pTCR, such as the Wnt signal- That GATA-3 is required for postcommitment survival
of SP CD4 cells is in agreement with the work of others.ing pathway, a possibility that we have yet to explore
(reviewed in Staal and Clevers, 2003). Recently it has CD2-driven GATA-3 expression in thymocytes did not
alter CD4/8 lineage commitment in the thymus but ratherbeen shown that thymic expression of constitutively ac-
tive -catenin induces differentiation of DP thymocytes inhibited the maturation and survival of committed CD8
peripheral T cells, inducing apoptosis (Nawijn et al.,in the absence of intracellular TCR protein and pTCR
expression (Gounari et al., 2001). Whether GATA-3 is 2001), results that were confirmed, more recently, using
in vitro reaggregate fetal thymic organ culture (Rg FTOC)sufficient to drive  selection in the absence of the pTCR
could be formally addressed by expressing GATA-3 in (Hernandez-Hoyos et al., 2003). These latter authors also
used overexpression of ROG to repress GATA-3 functionRAG-deficient thymocytes.
GATA-3 is expressed throughout thymic develop- and performed knockdown experiments using siRNA in
fetal thymocytes. While we found that the SP CD4 cellment, as is another important factor, Notch1. When
Notch1 is deleted in bone marrow precursors, B cells number in our animals was drastically reduced, these au-
thors report a more modest decrease in SP CD4 cell per-develop in the thymus, demonstrating that Notch1 is
required to suppress B cell lineage development from centage, which might be explained by residual GATA-3
protein due to incomplete suppression by ROG or siRNAcommon lymphoid progenitors (Radtke et al., 1999; Wil-
son et al., 2001). Deletion of Notch1 by the lck-cre pro- (Hernandez-Hoyos et al., 2003). Our results also differ
in that we observed preservation of SP CD8 cell number,moter, on the other hand, results in a partial DN3 arrest
strikingly similar to that seen in our mice, due to deficient while in the latter study enhancement was seen (Hernan-
dez-Hoyos et al., 2003). The relative proportion of SPTCR gene rearrangement (Wolfer et al., 2002). The fact
that Notch1 acts at two stages of early thymocyte devel- CD4 and CD8 cells seen in Rg FTOC is known to vary
widely with the stage of embryonic development andopment that also require GATA-3, the CLP stage and
the DN3 stage, raises the possibility that these pathways the number of days in culture; we thus attribute the
disparity between our results and those of Hernandez-intersect. In vitro studies have shown that GATA-2 is
required for Notch1 to mediate granulocytic differentia- Hoyos and colleagues to the fact that in vitro Rg FTOC
does not precisely recapitulate in vivo adult thymic de-tion of a myeloid cell line (Kumano et al., 2001), but
studies of GATA-3 and Notch1 are lacking. Notch1 defi- velopment. Alternatively, nonspecific effects of ROG ex-
pression or of siRNA on molecules other than GATA-3ciency in the DP stage using CD4-cre resulted in normal
thymic development (Wolfer et al., 2001); if GATA-3’s in the in vitro setting could be responsible. Taken to-
gether, our findings show that while positive selection,role in maintaining or generating CD4 SP thymocytes
involves the Notch signaling pathway, the interaction lineage commitment, and the maturation of SP CD8 cells
remain intact in GATA-3-deficient mice, the survival ormay involve other Notch factors such as Notch2 or
Notch3, or may take place at a point downstream of maintenance of SP CD4 thymocytes is critically depen-
dent on GATA-3.Notch action.
We also demonstrate that GATA-3 is indispensable The manifestations of GATA-3 deficiency that we re-
port here reflect the pluripotency of this important tran-for the survival or maintenance of SP CD4 thymocytes,
which were nearly absent in animals in which GATA-3 scription factor, and yet the direct gene targets respon-
sible for these phenotypes are unknown. Given thatwas deleted before the DP stage. The phenotype ob-
served in these mice is very similar to that of two mice GATA-3 is required at multiple steps of thymocyte devel-
opment, the downstream targets may differ at eachdescribed in the literature, the HD mutant mice (Keefe
et al., 1999) and mice deficient in CD83 (Fujimoto et stage of differentiation, and stage-specific cofactors
may be required to elicit the expression of appropriateal., 2002). The HD mice, deficient in an unknown gene
product, have a profound deficiency in CD4 T cells. genes at each step. The dissection of these effects
should prove fruitful in furthering our understanding ofWhen HD mice were crossed with MHC class II-
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Detection of TCR Gene Rearrangementthymic development and the generation of a complete
Detection of TCR gene rearrangement was performed accordingand fully responsive immune system.
to the method described in Wolfer et. al. (2002). In brief, oligonucleo-
tides were used to amplify V8.1, V5.2, and DJ segments. Primers
Experimental Procedures to amplify Thy-1 were also included in each mixture. PCR products
were separated on a 1.2% agarose gel and transferred onto Hybond
Generation of Flox-Flox GATA-3 Mice N membrane (Amersham Biosciences, Piscataway, NJ). Southern
and Other Transgenic Animals blotting was performed with gel purified DJ PCR amplification
The targeting construct is shown in Figure 1A. The backbone was product. Membranes were then stripped and reprobed with a Thy-1
derived from pPNT (Tybulewicz et al., 1991). Sequences encoding probe to confirm equal loading.
a loxP site flanked by XbaI and BamHI and encoding an EcoRI site,
loxP site, PGK promoter, and splice site between exon 3 and 4 were
Real-Time PCR Analysis of TCR Constant Regioninserted to generate the 3 and 5 loxP sites, respectively. The 5
Thymocyte RNA was isolated using Trizol reagent (Invitrogen, Carls-homology region was derived from a BamHI-EcoRI 5.8 kb fragment
bad, CA) according to the manufacturer’s recommendations. First-from 129 genomic DNA that encompasses part of exon 3 and the
strand cDNA was prepared after DNase I treatment (Invitrogen),following intronic region. The 3 homology region was derived from
and primers were used to detect TCR constant region transcriptsa 2.4 kb EcoRI-HindIII fragment from the intron between exons 5
(forward, TCAGTGCAGAGGCCTGGG; reverse, GACAGAACCCCCand 6. The sequence encoding EGFP was obtained from a BamHI-
TGATGATAGG) and -actin (forward, GCTCTGGCTCCTAGCACAflIII 1 kb fragment from pEGFP1 (Clontech, Palo Alto, CA). One
CAT; reverse, GCCACCGATCCACACCGCGT). A FAM-labeled probehundred twenty-nine murine embryonic stem cells and murine em-
(Operon Technologies, Alameda, CA) was used for detection ofbryonic fibroblasts were purchased from Incyte Genomics (Palo
-actin message (TCAAGATCATTGCTCCTCCTGAGCGC). BecauseAlto, CA). A 1.1 kb NcoI-KpnI probe from exon 6 detecting 6.5 kb
of the rarity of the DN3 and DN4 populations, thymocytes from sixwild-type and 3.9 kb and 1.5 kb floxed KpnI fragments was used to
to nine mice were pooled for the analysis. Reactions were run inconfirm recombination at the 3 end. A 0.3 kb BglII-EcoRI probe
triplicate on a 7700 Sequence Detector (Applied Biosystems, Fosterfrom intron 2 detecting 10 kb wild-type and 13 kb floxed ClaI-EcoRV
City, CA) using 10 pmol of each primer, 0.2 ul of cDNA, and eitherfragments was used to confirm recombination at the 5 end. The
2 Taqman or 2 SYBR green reagent (Applied Biosystems) in asequences of the primers depicted in Figure 1A are as follows:
total reaction of 25 ul.primer 1, CCCCTTTCCCGGCTCTATCTT; primer 2, GGGCCGGT
TCTGCCCATT; primer 3, CCTCCCCTACCCGGTAGAATT; primer 4,
GGCATTCTCGCACGCTTCAAA; primer 5, GGGGCCGGTTCTGCCC Thymocyte Stimulation and Immunoprecipitation
ATTCATTTTATTGGTAGAGTCCGC; primer 6, GGATGGGCACCACC For phosphotyrosine analysis, stimulation of thymocytes and prepa-
CCGGTGAA. Primers 1, 2, and 3 in Figure 1A were used to simultane- ration of lysates were performed according to the method of Thien
ously detect wild-type and floxed alleles after 30 cycles. Alterna- et al. (2003) with modifications. Single-cell suspensions were made,
tively, wild-type bands were detected individually using oligos 1 and and 5 106 cells were chilled on ice in RPMI containing 10% fetal calf
2 and floxed alleles using the primers 4 and 5. serum (Hyclone, Logan, UT) at 50  106/ml. Biotinylated antibodies
lck-cre and CD4-cre transgenic animals were obtained from Dr. against CD3	 (500A2) and CD4 (GK1.5) obtained from BD Phar-
Christopher Wilson and screened as described (Lee et al., 2001). mingen (San Diego, CA) were added at 10 
g/ml. Cells were warmed
DO11.10 transgenic animals (Murphy et al., 1990) were purchased at 37C for 2 min in a shaking water bath, and streptavidin (Sigma-
from Taconic (Germantown, NY). Mice were housed in a specific Aldrich, St. Louis, MO) was added at 40 
g/ml for 5 min. Reactions
pathogen-free facility, and experiments were done in accordance were quenched with ice-cold PBS, and the cell pellet was lysed in
with the institutional guidelines for animal care at Dana-Farber Can- ice-cold RIPA buffer containing 50 mM Tris (pH 7.5), 150 mM NaCl,
cer Institute and Harvard School of Public Health under approved 1% Triton X-100, 10 mM NaF, 1 mM sodium vanadate, 0.5 mM
protocols. FF/lck-cre animals were backcrossed at least five to six PMSF, and protease inhibitors.
generations onto the BALB/c background while FF/CD4-cre animals For specific lck immunoprecipitation, cells were stimulated as
were on the C57BL/6 background. FF/CD4-cre animals crossed with above in the absence of serum, and the pellet was lysed in ice-cold
DO11.10 transgenic animals were backcrossed to BALB/c back- lysis buffer containing 20 mM Tris (pH 7.5), 100 mM NaCl, 1% Triton
ground at least three generations, and appropriate MHC typing was X-100, 20 mM NaF, 1 mM sodium vanadate, 10 mM -glycerophos-
confirmed. All animals were sacrificed for analysis between 4 and phate, 1 mM PMSF, and protease inhibitor cocktail (Mini-Complete,
6 weeks of age. Roche). Clarified lysates were incubated with anti-lck antibody (Cell
Signaling Technology, Beverly, MA) and then with protein G Sepha-
rose beads (Amersham Biosciences, Piscataway, NJ). The beadsFlow Cytometry
were washed extensively with lysis buffer, boiled in sample buffer,Staining was performed with fluorescent-tagged antibodies to CD4
and loaded onto SDS-PAGE.(RM4-5), CD8 (536.7), CD44 (IM7), CD25 (PC61) (BD Pharmingen,
San Diego, CA), and FITC-Annexin V (Oncogene Research Products,
La Jolla, CA). Expression of the DO11.10 transgene was detected Western Blotting
either using anti-idiotype antibody KJ1-26 (Caltag, Burlingame, CA) For Western blotting of GATA-3, thymocytes were lysed in Laemmli
or by anti-V 8.1/8.2 antibody (MR5-2) (BD Pharmingen). Analysis buffer, separated by SDS-PAGE, and transferred onto PVDF (Perkin
was performed on either a FACSort or a FACSCalibur machine (BD Elmer, Boston, MA) by wet transfer. Membranes were incubated
Biosciences, San Jose, CA) using FSC and SSC to gate on live cells. either with rabbit polyclonal antiserum (laboratory of J.M. Leiden)
Intracellular staining of TCR (H57-597, BD Pharmingen) (Wolfer et or with mouse monoclonal antibody (Santa Cruz Biotechnology,
al., 2002) and analysis of E cells and L cells (Hoffman et al., 1996) Santa Cruz, CA). GATA-3 was then detected using HRP-conjugated
were performed as described. Cell sorting was performed on a Mo- goat anti-rabbit or rabbit anti-mouse secondary antibody (Zymed,
Flo cell sorting machine (Cytomation, Fort Collins, CO). For some South San Francisco, CA) and ECL (Perkin Elmer, Boston, MA). For
preparations DN thymocytes were enriched by magnetic depletion phosphotyrosine analysis, membranes were blocked in 1% BSA and
using CD4 or CD8 beads (Miltenyi Biotec, Auburn, CA). incubated with mouse anti-phosphotyrosine antibody (4G10, gift of
Dr. Hamid Band), protein A-conjugated HRP secondary (Zymed),
and subjected to ECL (Perkin Elmer). For detection of phosphory-PCR to Detect GATA-3 Zinc Finger Region Deletion
Primers 4, 5, and 6 as depicted in Figure 1A were used to simultane- lated active lck, lck immunoprecipitates were subjected to Western
blotting using anti-phospho-Src antibody, and membranes wereously detect floxed and deleted alleles using genomic DNA isolated
from thymocytes as template. After 35 cycles of amplification (45 s stripped and reprobed with anti-lck antibody. Anti-pErk was de-
tected by direct Western analysis. Anti-lck (#2752), anti-phospho-each at 94C, 55C, and 72C), PCR products were run on a 2%
agarose gel, and flox band (432 bp) and deleted band (174 bp) were Src (#2101), and anti-pErk (#9101) antibodies were purchased from
Cell Signaling Technology (Beverly, MA).visualized by ethidium bromide staining.
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